FUS and amyotrophic lateral sclerosis: By contrast, Matrin3 does not contain any PrLDs, yet it does contain large regions of disorder, and, similar to FUS, almost all of the ALS-associated amino acid substitutions (Figure 6A) and most of the documented post-translational modifications (Figure 6B) occur in Matrin3’s disordered regions.